Ethylisopropyltryptamine

EiPT
Clinical data
Other names	EiPT; N-Ethyl-N-isopropyltryptamine
Routes of; administration	Oral
Drug class	Psychedelic drug; Serotonergic psychedelic
ATC code	none;
Legal status
Legal status	DE: NpSG (Industrial and scientific use only); UK: Class A;
Pharmacokinetic data
Duration of action	4–6 hours
Identifiers
	IUPAC name N-ethyl-N-[2-(1H-indol-3-yl)ethyl]propan-2-amine;
CAS Number	848130-11-0 ;
PubChem CID	44719455;
ChemSpider	21106305 ;
UNII	63J8CXV5Z8;
CompTox Dashboard (EPA)	DTXSID60660346 ;
Chemical and physical data
Formula	C15H22N2
Molar mass	230.355 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	71 to 73 °C (160 to 163 °F)
	SMILES CCN(C(C)C)CCc1c[nH]c2ccccc12;
	InChI InChI=1S/C15H22N2/c1-4-17(12(2)3)10-9-13-11-16-15-8-6-5-7-14(13)15/h5-8,11-12,16H,4,9-10H2,1-3H3 ; Key:HQZLBYMOYCJZRF-UHFFFAOYSA-N ;
	(verify)

Ethylisopropyltryptamine (EiPT), also known as N-ethyl-N-isopropyltryptamine, is a psychedelic drug of the tryptamine family. It is taken orally.

EiPT appears to have been first synthesized and described by Alexander Shulgin.